Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Boackle, SA; Holers, VM; Chen, XJ; Szakonyi, G; Karp, DR; Wakeland, EK; Morel, L
   Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein
   IMMUNITY
   
   S.A. Boackle et al., "Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein", IMMUNITY, 15(5), 2001, pp. 775-785
2. Prechl, J; Erdei, A
   Immunomodulatory functions of murine CR1/2
   IMMUNOPHARMACOLOGY
   
   J. Prechl e A. Erdei, "Immunomodulatory functions of murine CR1/2", IMMUNOPHARM, 49(1-2), 2000, pp. 117-124
3. Yan, J; Vetvicka, V; Xia, Y; Hanikyrova, M; Mayadas, TN; Ross, GD
   Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan
   IMMUNOPHARMACOLOGY
   
   J. Yan et al., "Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan", IMMUNOPHARM, 46(1), 2000, pp. 39-54
4. Oudin, S; Libyh, MT; Goossens, D; Dervillez, X; Philbert, F; Reveil, B; Bougy, F; Tabary, T; Rouger, P; Klatzmann, D; Cohen, JHM
   A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes
   JOURNAL OF IMMUNOLOGY
   
   S. Oudin et al., "A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes", J IMMUNOL, 164(3), 2000, pp. 1505-1513
5. Cohen, JHM; Atkinson, JP; Klickstein, LB; Oudin, S; Subramanian, VB; Moulds, JM
   The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of thepolymorphisms
   MOLECULAR IMMUNOLOGY
   
   J.H.M. Cohen et al., "The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of thepolymorphisms", MOL IMMUNOL, 36(13-14), 1999, pp. 819-825
6. Baiu, DC; Prechl, J; Tchorbanov, A; Molina, HD; Erdei, A; Sulica, A; Capel, PJA; Hazenbos, WLW
   Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors
   JOURNAL OF IMMUNOLOGY
   
   D.C. Baiu et al., "Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors", J IMMUNOL, 162(6), 1999, pp. 3125-3130
7. Oliver, AM; Martin, F; Kearney, JF
   IgM(high)CD21(high) lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells
   JOURNAL OF IMMUNOLOGY
   
   A.M. Oliver et al., "IgM(high)CD21(high) lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells", J IMMUNOL, 162(12), 1999, pp. 7198-7207
8. CARROLL MC
   CD21 CD35 IN B-CELL ACTIVATION
   Seminars in immunology
   
   M.C. Carroll, "CD21 CD35 IN B-CELL ACTIVATION", Seminars in immunology, 10(4), 1998, pp. 279-286
9. FANG YF; XU CG; FU YX; HOLERS VM; MOLINA H
   EXPRESSION OF COMPLEMENT RECEPTOR-1 AND RECEPTOR-2 ON FOLLICULAR DENDRITIC CELLS IS NECESSARY FOR THE GENERATION OF A STRONG ANTIGEN-SPECIFIC IGG RESPONSE
   The Journal of immunology
   
   Y.F. Fang et al., "EXPRESSION OF COMPLEMENT RECEPTOR-1 AND RECEPTOR-2 ON FOLLICULAR DENDRITIC CELLS IS NECESSARY FOR THE GENERATION OF A STRONG ANTIGEN-SPECIFIC IGG RESPONSE", The Journal of immunology, 160(11), 1998, pp. 5273-5279
10. DERVILLEZ X; OUDIN S; LIBYH MT; TABARY T; REVEIL B; PHILBERT F; BOUGY F; PLUOT M; COHEN JHM
    CATABOLISM OF THE HUMAN ERYTHROCYTE C3B C4B RECEPTOR (CR-1, CD35) - VESICULATION AND/OR PROTEOLYSIS/
    Immunopharmacology
    
    X. Dervillez et al., "CATABOLISM OF THE HUMAN ERYTHROCYTE C3B C4B RECEPTOR (CR-1, CD35) - VESICULATION AND/OR PROTEOLYSIS/", Immunopharmacology, 38(1-2), 1997, pp. 129-140
11. TAYLOR RP; FERGUSON PJ; MARTIN EN; COOKE J; GREENE KL; GRINSPUN K; GUTTMAN M; KUHN S
    IMMUNE-COMPLEXES BOUND TO THE PRIMATE ERYTHROCYTE COMPLEMENT RECEPTOR(CR-1) VIA ANTI-CR-1 MABS ARE CLEARED SIMULTANEOUSLY WITH LOSS OF CR-1 IN A CONCERTED REACTION IN A RHESUS-MONKEY MODEL
    Clinical immunology and immunopathology
    
    R.P. Taylor et al., "IMMUNE-COMPLEXES BOUND TO THE PRIMATE ERYTHROCYTE COMPLEMENT RECEPTOR(CR-1) VIA ANTI-CR-1 MABS ARE CLEARED SIMULTANEOUSLY WITH LOSS OF CR-1 IN A CONCERTED REACTION IN A RHESUS-MONKEY MODEL", Clinical immunology and immunopathology, 82(1), 1997, pp. 49-59
12. ALEXANDER JJ; HE C; ADLER S; HOLERS VM; QUIGG RJ
    CHARACTERIZATION OF C3 RECEPTORS ON CULTURED RAT GLOMERULAR ENDOTHELIAL-CELLS
    Kidney international
    
    J.J. Alexander et al., "CHARACTERIZATION OF C3 RECEPTORS ON CULTURED RAT GLOMERULAR ENDOTHELIAL-CELLS", Kidney international, 51(4), 1997, pp. 1124-1132
13. IMRIE HJ; JONES DRE
    COMPLEMENT COATING OF ERYTHROCYTES IS REDUCED FOLLOWING THEIR INTERACTION WITH NEUTROPHILS IN-VITRO WITHOUT LOSS OF COMPLEMENT-RECEPTOR-1 (CR-1)
    Clinical and experimental immunology
    
    H.J. Imrie e D.R.E. Jones, "COMPLEMENT COATING OF ERYTHROCYTES IS REDUCED FOLLOWING THEIR INTERACTION WITH NEUTROPHILS IN-VITRO WITHOUT LOSS OF COMPLEMENT-RECEPTOR-1 (CR-1)", Clinical and experimental immunology, 109(1), 1997, pp. 217-222
14. RASMUSSON BJ; CARPENTIER JL; PACCAUD JP; MAGNUSSON KE
    THE N-FORMYL METHIONYL PEPTIDE, FORMYL-METHIONYL-LEUCYL-PHENYLALANINE(FMLF) INCREASES THE LATERAL DIFFUSION OF COMPLEMENT RECEPTOR-1 (CR1 CD35) IN HUMAN NEUTROPHILS - A CAUSATIVE ROLE FOR OXIDATIVE METABOLITES/
    Bioscience reports
    
    B.J. Rasmusson et al., "THE N-FORMYL METHIONYL PEPTIDE, FORMYL-METHIONYL-LEUCYL-PHENYLALANINE(FMLF) INCREASES THE LATERAL DIFFUSION OF COMPLEMENT RECEPTOR-1 (CR1 CD35) IN HUMAN NEUTROPHILS - A CAUSATIVE ROLE FOR OXIDATIVE METABOLITES/", Bioscience reports, 16(5), 1996, pp. 391-404
15. MOLINA H; HOLERS VM; LI B; FANG YF; MARIATHASAN S; GOELLNER J; STRAUSSSCHOENBERGER J; KARR RW; CHAPLIN DD
    MARKEDLY IMPAIRED HUMORAL IMMUNE-RESPONSE IN MICE DEFICIENT IN COMPLEMENT RECEPTOR-1 AND RECEPTOR-2
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    H. Molina et al., "MARKEDLY IMPAIRED HUMORAL IMMUNE-RESPONSE IN MICE DEFICIENT IN COMPLEMENT RECEPTOR-1 AND RECEPTOR-2", Proceedings of the National Academy of Sciences of the United Statesof America, 93(8), 1996, pp. 3357-3361
16. QUIGG RJ; HOLERS VM
    CHARACTERIZATION OF RAT COMPLEMENT RECEPTORS AND REGULATORY PROTEINS - CR-2 AND CRRY ARE CONSERVED, AND THE C3B RECEPTOR OF NEUTROPHILS ANDPLATELETS IS DISTINCT FROM CR-1
    The Journal of immunology
    
    R.J. Quigg e V.M. Holers, "CHARACTERIZATION OF RAT COMPLEMENT RECEPTORS AND REGULATORY PROTEINS - CR-2 AND CRRY ARE CONSERVED, AND THE C3B RECEPTOR OF NEUTROPHILS ANDPLATELETS IS DISTINCT FROM CR-1", The Journal of immunology, 155(3), 1995, pp. 1481-1488
17. KIM YU; KINOSHITA T; MOLINA H; HOURCADE D; SEYA T; WAGNER LM; HOLERS VM
    MOUSE COMPLEMENT REGULATORY PROTEIN CRRY P65 USES THE SPECIFIC MECHANISMS OF BOTH HUMAN DECAY-ACCELERATING FACTOR AND MEMBRANE COFACTOR PROTEIN/
    The Journal of experimental medicine
    
    Y.U. Kim et al., "MOUSE COMPLEMENT REGULATORY PROTEIN CRRY P65 USES THE SPECIFIC MECHANISMS OF BOTH HUMAN DECAY-ACCELERATING FACTOR AND MEMBRANE COFACTOR PROTEIN/", The Journal of experimental medicine, 181(1), 1995, pp. 151-159
18. YASKANIN DD; WAXMAN FJ
    EXPRESSION OF THE CR-1 RECEPTOR ON HUMAN LEUKEMIA-DERIVED CD4(-CELL LINES() T)
    Cellular immunology
    
    D.D. Yaskanin e F.J. Waxman, "EXPRESSION OF THE CR-1 RECEPTOR ON HUMAN LEUKEMIA-DERIVED CD4(-CELL LINES() T)", Cellular immunology, 163(1), 1995, pp. 139-147
19. DAVIES KA; SCHIFFERLI JA; WALPORT MJ
    COMPLEMENT DEFICIENCY AND IMMUNE-COMPLEX DISEASE
    Perspectives in mathematical logic
    
    K.A. Davies et al., "COMPLEMENT DEFICIENCY AND IMMUNE-COMPLEX DISEASE", Perspectives in mathematical logic, 15(4), 1994, pp. 397-416
20. HARA T; FUKUDA H; MASAOKA T; MATSUMOTO M; SEYA T
    DEVELOPMENT OF AN ELISA ASSAY FOR SOLUBLE CD35 (C3B C4B RECEPTOR) - HIGH-LEVELS OF SOLUBLE CD35 IN LE-POSITIVE PATIENTS WITH HEMATOLOGICAL MALIGNANCIES/
    Immunology letters
    
    T. Hara et al., "DEVELOPMENT OF AN ELISA ASSAY FOR SOLUBLE CD35 (C3B C4B RECEPTOR) - HIGH-LEVELS OF SOLUBLE CD35 IN LE-POSITIVE PATIENTS WITH HEMATOLOGICAL MALIGNANCIES/", Immunology letters, 41(2-3), 1994, pp. 249-253
21. MOLINA H; KINOSHITA T; WEBSTER CB; HOLERS VM
    ANALYSIS OF C3B C3D BINDING-SITES AND FACTOR-I COFACTOR REGIONS WITHIN MOUSE COMPLEMENT RECEPTOR-1 AND RECEPTOR-2/
    The Journal of immunology
    
    H. Molina et al., "ANALYSIS OF C3B C3D BINDING-SITES AND FACTOR-I COFACTOR REGIONS WITHIN MOUSE COMPLEMENT RECEPTOR-1 AND RECEPTOR-2/", The Journal of immunology, 153(2), 1994, pp. 789-795
22. FOLEY S; LI B; DEHOFF M; MOLINA H; HOLERS VM
    MOUSE CRRY P65 IS A REGULATOR OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION/
    European Journal of Immunology
    
    S. Foley et al., "MOUSE CRRY P65 IS A REGULATOR OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION/", European Journal of Immunology, 23(6), 1993, pp. 1381-1384
23. MARTIN BK; WEIS JH
    MURINE MACROPHAGES LACK EXPRESSION OF THE CR-2-145 (CR-2) AND CR-2-190 (CR-1) GENE-PRODUCTS
    European Journal of Immunology
    
    B.K. Martin e J.H. Weis, "MURINE MACROPHAGES LACK EXPRESSION OF THE CR-2-145 (CR-2) AND CR-2-190 (CR-1) GENE-PRODUCTS", European Journal of Immunology, 23(11), 1993, pp. 3037-3042